Cargando…
Antioxidants Reduce Muscular Dystrophy in the dy(2J)/dy(2J) Mouse Model of Laminin α2 Chain-Deficient Muscular Dystrophy
Congenital muscular dystrophy with laminin α2 chain-deficiency (LAMA2-CMD) is a severe neuromuscular disorder without a cure. Using transcriptome and proteome profiling as well as functional assays, we previously demonstrated significant metabolic impairment in skeletal muscle from LAMA2-CMD patient...
Autores principales: | Harandi, Vahid M., Moreira Soares Oliveira, Bernardo, Allamand, Valérie, Friberg, Ariana, Fontes-Oliveira, Cibely C., Durbeej, Madeleine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7139799/ https://www.ncbi.nlm.nih.gov/pubmed/32197453 http://dx.doi.org/10.3390/antiox9030244 |
Ejemplares similares
-
Bortezomib Does Not Reduce Muscular Dystrophy in the dy(2J)/dy(2J) Mouse Model of Laminin α2 Chain-Deficient Muscular Dystrophy
por: Körner, Zandra, et al.
Publicado: (2016) -
Early skeletal muscle pathology and disease progress in the dy(3K)/dy(3K) mouse model of congenital muscular dystrophy with laminin α2 chain-deficiency
por: Gawlik, Kinga I., et al.
Publicado: (2019) -
Exploratory Profiling of Urine MicroRNAs in the
dy(2J)/dy(2J) Mouse Model
of LAMA2-CMD: Relation to Disease Progression
por: Moreira Soares Oliveira, Bernardo, et al.
Publicado: (2018) -
Effects of metformin on congenital muscular dystrophy type 1A disease progression in mice: a gender impact study
por: Fontes-Oliveira, Cibely C., et al.
Publicado: (2018) -
Natural disease history of the dy(2J) mouse model of laminin α2 (merosin)-deficient congenital muscular dystrophy
por: Pasteuning-Vuhman, S., et al.
Publicado: (2018)